UPEX-MED

Upex-Med is a South Korean biotechnology company specializing in the development of exosome-based therapeutics and diagnostics. The company utilizes its proprietary UPEX platform, which enables the high-purity isolation and engineering of exosomes for targeted drug delivery. Their current research and development pipeline focuses on high-unmet-need areas, including neurodegenerative diseases like Alzheimer's, metabolic disorders such as non-alcoholic steatohepatitis (NASH), and various cancers. By leveraging exosomes as natural delivery vehicles, Upex-Med aims to overcome traditional barriers in drug delivery, such as the blood-brain barrier. The company's technology is designed to provide a scalable solution for the production of high-purity exosomes, addressing a major bottleneck in the field.